TKNO
Alpha Teknova, Inc.About TKNO
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Company
- Headquarters
- Hollister, CA
- Employees
- 158 (2026)
- Listed
- Jun 25, 2021
- Exchange
- Nasdaq
- Website
- teknova.com
- SEC industry
- In Vitro & in Vivo Diagnostic Substances
- Cylvex sector
- Health Care · Diagnostics
Diagnostics
- Market cap #26 of 39
- P/B #8 of 37
Ranked highest first among stocks Cylvex covers.
- NTRANatera, Inc.$56.37B+0.63%
- IDXXIdexx Laboratories Inc$55.09B+4.06%
- LHLabcorp Holdings Inc.$29.86B+3.92%
- DGXQuest Diagnostics Inc.$28.21B+3.46%
- GHGuardant Health, Inc.$22.65B-3.54%
Financial summary
Related companies
About
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
From company filings and market data · Not investment advice
Price data
From daily bars
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.